La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Sharecare Gestione

Gestione criteri di controllo 3/4

Sharecare's Il CEO è Brent Layton, nominato in Jan2024, ha un mandato di meno di un anno. possiede direttamente 0.39% delle azioni della società, per un valore di $ 2.03M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.5 anni e 3.1 anni.

Informazioni chiave

Brent Layton

Amministratore delegato

US$235.0k

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	less than a year
Proprietà del CEO	0.4%
Durata media del management	3.5yrs
Durata media del Consiglio di amministrazione	3.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

Sharecare awarded three-year NCQA accreditation for wellness and health promotion

Sep 19

Sharecare Non-GAAP EPS of -$0.02 beats by $0.07, revenue of $103.8M beats by $0.87M

Aug 10

Analysts Have Lowered Expectations For Sharecare, Inc. (NASDAQ:SHCR) After Its Latest Results

Apr 03

Sharecare, Inc. (NASDAQ:SHCR) Analysts Just Slashed This Year's Estimates

Apr 02

Sharecare CEO Jeff Arnold - Healthcare Ripe For Disruption (Video)

Nov 23

AMMINISTRATORE DELEGATO

Brent Layton (55 yo)

less than a year

Mandato

US$235,000

Compensazione

Mr. Brent Davis Layton serves as Director of Homeward Health Inc. since June 2023. He is Director at Sharecare, Inc. from January 11, 2023 and is its CEO since January 2, 2024. He was Senior Advisor to the...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Jeffrey Arnold	Founder & Executive Chairman	12.6yrs	US$18.19m	2.77% $ 14.2m
Brent Layton	CEO & Director	less than a year	US$235.00k	0.39% $ 2.0m
Dawn Whaley	President & Chief Marketing Officer	14.6yrs	US$7.28m	0.46% $ 2.4m
Justin Ferrero	President & CFO	14.6yrs	US$7.27m	0.44% $ 2.3m
Shannon Bagley	Chief Operating Officer	no data	Nessun dato	Nessun dato
Michael Blalock	Chief Accounting Officer & Principal Accounting Officer	2.6yrs	Nessun dato	0.043% $ 221.7k
Harsha Panyadahundi	Chief Technology Officer	2.1yrs	Nessun dato	Nessun dato
Walter De Brouwer	Chief Scientific Officer	3.5yrs	Nessun dato	Nessun dato
Colin Daniel	Chief Administrative Officer	2.6yrs	Nessun dato	0.13% $ 677.1k
Henry Jay	General Counsel & Diversity Officer	no data	Nessun dato	Nessun dato
Jen Hall	Executive Vice President of Corporate Communications	3.6yrs	Nessun dato	Nessun dato
Dermot Waters	Executive Vice President of Marketing	3.6yrs	Nessun dato	Nessun dato

3.5yrs

Durata media

53.5yo

Età media

Gestione esperta: Il team dirigenziale di SHCR è considerato esperto (durata media dell'incarico 3.5 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Jeffrey Arnold	Founder & Executive Chairman	12.6yrs	US$18.19m	2.77% $ 14.2m
Brent Layton	CEO & Director	1.6yrs	US$235.00k	0.39% $ 2.0m
Michael Roizen	Member of Advisory Board	no data	Nessun dato	Nessun dato
John Chadwick	Lead Independent Director	3.1yrs	US$290.00k	0.086% $ 438.8k
Jeffrey Allred	Independent Director	3.1yrs	US$252.54k	0.19% $ 973.5k
Vincent DeVita	Member of Advisory Board	no data	Nessun dato	Nessun dato
Tanya Altmann	Member of Advisory Board	no data	Nessun dato	Nessun dato
Barbara Ficarra	Member of Advisory Board	no data	Nessun dato	Nessun dato
Arthur Crowley	Member of Advisory Board	no data	Nessun dato	Nessun dato
David Demartini	Member of Advisory Board	no data	Nessun dato	Nessun dato
Patricia Geraghty	Member of Advisory Board	no data	Nessun dato	Nessun dato
Sandro Galea	Independent Director	3.1yrs	US$253.23k	0.038% $ 193.2k

3.1yrs

Durata media

55.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di SHCR sono considerati esperti (durata media dell'incarico 3.1 anni).

Sharecare Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Founder & Executive Chairman exercised options and sold US$245k worth of stock

Chief Administrative Officer recently sold US$154k worth of stock

President & CFO notifies of intention to sell stock

Sharecare, Inc., Annual General Meeting, Jun 13, 2024

Sharecare, Inc Appoints Nicole Torraco to its Board of Directors

Founder & Executive Chairman exercised options and sold US$216k worth of stock

Recent updates

Founder & Executive Chairman exercised options and sold US$245k worth of stock

Chief Administrative Officer recently sold US$154k worth of stock

President & CFO notifies of intention to sell stock

New minor risk - Shareholder dilution

Altaris, LLC entered into a definitive agreement to acquire Sharecare, Inc. (NasdaqGS:SHCR) for approximately $520 million.

Price target decreased by 14% to US$1.50

Sharecare, Inc., Annual General Meeting, Jun 13, 2024

Sharecare, Inc. to Report Q1, 2024 Results on May 09, 2024

Rosen Law Firm Files A Class Action Lawsuit Against Sharecare Inc

Rosen Law Firm Files A Class Action Lawsuit Against Sharecare Inc

Sharecare Receives a Letter from the Listing Qualifications Department of the Nasdaq Stock Market

Sharecare, Inc Appoints Nicole Torraco to its Board of Directors

Sharecare, Inc. announced delayed annual 10-K filing

Sharecare, Inc. to Report Q4, 2023 Results on Mar 13, 2024

Founder & Executive Chairman exercised options and sold US$216k worth of stock

Founder & Executive Chairman exercised options and sold US$660k worth of stock

We Think Sharecare (NASDAQ:SHCR) Can Afford To Drive Business Growth

Price target decreased by 10.0% to US$3.00

Sharecare, Inc. Announces CEO Changes

Third quarter 2023 earnings released: US$0.07 loss per share (vs US$0.078 loss in 3Q 2022)

Sharecare, Inc. to Report Q3, 2023 Results on Nov 09, 2023

New minor risk - Share price stability

Consensus EPS estimates fall by 12%

We're Hopeful That Sharecare (NASDAQ:SHCR) Will Use Its Cash Wisely

Second quarter 2023 earnings: EPS misses analyst expectations

Sharecare, Inc. Provides Revenue Guidance for the Third Quarter Ending September 30, 2023 and Fiscal Year Ending December 31, 2023

Sharecare Expands Suite of Customer Activation and Management Solutions to Support Patient Education and Improve the Care Journey

Sharecare, Inc. to Report Q2, 2023 Results on Aug 09, 2023

There's No Escaping Sharecare, Inc.'s (NASDAQ:SHCR) Muted Revenues

Sharecare, Inc. (NasdaqGS:SHCR) announces an Equity Buyback for $50 million worth of its shares.

Consensus EPS estimates fall by 16%

Consensus EPS estimates fall by 61%

Sharecare, Inc. Revises Revenue Guidance for the Fiscal Year Ending December 31, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Key Executive exercised options and sold US$94k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

We Think Sharecare (NASDAQ:SHCR) Needs To Drive Business Growth Carefully

Sharecare Launches VR Program to Improve Well-Being of American Workforce and Bring Innovation to Exercise

Sharecare Launches Virtual Model of Its Medicare-Reimbursable Cardiac Rehabilitation Program, Ornish Lifestyle Medicine

Price target increased to US$3.50

Sharecare, Inc. Appoints Brent Layton to Its Board of Directors and Audit Committee

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Sharecare, Inc. to Report Q3, 2022 Results on Nov 10, 2022

Price target decreased to US$3.40

Sharecare Announces Nine New Digital Solutions Designed to Engage, Educate, and Support People in Managing Their Health

Sharecare Receives Three-Year NCQA Accreditation for Wellness and Health Promotion

Sharecare awarded three-year NCQA accreditation for wellness and health promotion

Sharecare Launches Self-Service Software Platform to Enable Independent Decentralized Clinical Research

Consensus EPS estimates fall by 69%

Second quarter 2022 earnings: EPS misses analyst expectations

Sharecare Non-GAAP EPS of -$0.02 beats by $0.07, revenue of $103.8M beats by $0.87M

Sharecare, Inc. to Report Q2, 2022 Results on Aug 10, 2022

Sharecare Names Harsha Panyadahundi Chief Technology Officer

Consensus forecasts updated

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Sharecare, Inc. (NasdaqGS:SHCR) announces an Equity Buyback for $50 million worth of its shares.

Sharecare Announces Sharecare+, its Whole Health, Payor-Agnostic Advocacy Solution

Price target decreased to US$6.67

Forecast breakeven date pushed back to 2023

Sharecare, Inc. to Report Q1, 2022 Results on May 12, 2022

Consensus revenue estimates fall by 12%

Analysts Have Lowered Expectations For Sharecare, Inc. (NASDAQ:SHCR) After Its Latest Results

Sharecare, Inc. (NASDAQ:SHCR) Analysts Just Slashed This Year's Estimates

Full year 2021 earnings: EPS misses analyst expectations

Sharecare, Inc. Provides Earning Guidance for the First Quarter Ending March 31, 2022 and Year Ending December 31, 2022

Sharecare, Inc. to Report Q4, 2021 Results on Mar 31, 2022

Price target decreased to US$10.50

Sharecare CEO Jeff Arnold - Healthcare Ripe For Disruption (Video)